NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow) 7. NEVER be a blind follower. LASTLY,...
Arrayfunction
:
Do you know much about $Nexalin Technology (NXL.US)$ 's tech? It's one of those I wish would work out but I am getting too many red flags. The tech just sounds like deep brain stimulation - which has never been shown to be effective enough for indication. The head scratcher about why a 2mmHg decrease in BP is a success when that's within margin of error for most devices. Also, it didn't reference that norepinephrine and dopamine are given in all kinds of MDD / chronic pain situations which will raise BP. I could certainly use an anti-hypertensive. My MAP tends to chill at about 115mmHg these days. But don't want to get my hopes up
NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow) 7. NEVER be a blind follower. LASTLY, If you do...
75
22
3
Report
104687047
:
Thank you for your hardwork. Also very good choice to remove your top picks. People should do their own DD and not copy trades like those scam gurus out there
$Allakos (ALLK.US)$ Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring Monday, 27th January at 7:00 am – AK006 did not demonstrate therapeutic activity in CSU – – Allakos will discontinue further development of AK006, reduce workforce by 75% and explore strategic alternatives – – Management to host conference call and webcast today at 8:30 am E.T. – SAN CARLOS, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) --...
Nitram74 : ok
Diaper Fund 4 MyGirl : Thank you![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f.png)
Bigdaddy Crypto :![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d-1f3fc.png)
![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d-1f3fc.png)
![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d-1f3fc.png)
Arrayfunction : Do you know much about $Nexalin Technology (NXL.US)$ 's tech? It's one of those I wish would work out but I am getting too many red flags. The tech just sounds like deep brain stimulation - which has never been shown to be effective enough for indication. The head scratcher about why a 2mmHg decrease in BP is a success when that's within margin of error for most devices. Also, it didn't reference that norepinephrine and dopamine are given in all kinds of MDD / chronic pain situations which will raise BP.![pleading_face 🥺](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f97a.png)
I could certainly use an anti-hypertensive. My MAP tends to chill at about 115mmHg these days. But don't want to get my hopes up
SunTzu lead Arrayfunction : dont ask about other stocks wirh jag
View more comments...